FDA Inspection
Lloyd Inc. of IowaLloyd Inc. of Iowa – FDA Inspection, Feb 2, 2018
Record Details
This FDA Inspection record concerns Lloyd Inc. of Iowa, with an inspection on February 2, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Alysia C. Alger (Company Rep)
- Brett R. Havranek (FDA Associated Person)
- Rita K. Vick (Issuing Officer)
View Company Profile
ID · e5fccc69-4125-400f-a8db-6efb3894b734
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1049376
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Lloyd Inc. of Iowa
8| Date | Classification | Office | Project area |
|---|---|---|---|
| November 6, 2025 | Not classified | Kansas City District Office | |
| September 15, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 28, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 20, 2015 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| April 16, 2013 | OAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Lloyd Inc. of Iowa
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.